Elisa Gonzalez Romero

After finishing the degree in Biology (University of Alicante, 2014) and the Master of Research in Molecular, Cellular and Genomic Biology (Universitat de València, 2015) she started working as graduate in the Research group in Molecular, Cellular and Genetic Biology (IIS La Fe, Valencia). In this group, he carried out gene editing studies using CRISPR/Cas 9 technology and other similar nucleases for the study of Usher Syndrome. In 2017 he joined the Hematology Research Group (IIS La Fe, Valencia) to develop her PhD developing models of myeloid neoplasms in different cell lines and in Caenorhabditis elegans through different variants of the CRISPR/Cas9 technology.